share_log

Vaccinex Shares Are Trading Lower. The Company Announced Results of Its Early Stage SIGNAL-AD Clinical Trial of Pepinemab Antibody in AD.

Vaccinex Shares Are Trading Lower. The Company Announced Results of Its Early Stage SIGNAL-AD Clinical Trial of Pepinemab Antibody in AD.

vaccinex股價下跌。公司公佈了其pepinemab抗體在AD早期信號-AD臨床試驗的結果。
Benzinga ·  14:58

Vaccinex Shares Are Trading Lower. The Company Announced Results of Its Early Stage SIGNAL-AD Clinical Trial of Pepinemab Antibody in AD.

Vaccinex的股價正在走低。該公司公佈了針對AD的Pepinemab抗體的早期SIGNAL-AD臨床試驗結果。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論